Communiqués Restart Life Sciences Corp.

Actions

HEAL

CA76134J2065

Recherche biotechnologique et médicale

Marché Fermé - Canadian Securities Exchange Autres places de cotation 16:08:49 07/08/2026			Varia. 5j.	Varia. 1 janv.
0,0700 ^CAD	-17,65%		-17,65%	-44,00%

21/07	Restart Life Sciences lance sa plateforme d'e-commerce optimisée par l'IA et élargit la gamme de produits Holy Crap Foods	CI
14/07	Restart Life Sciences Corp. et le Richardson Centre for Food Technology and Research de l'Université du Manitoba collaborent pour la phase de pré-production de nouvelles structures protéiques	CI

Communiqués

29/07	Restart Life Sciences Announces Strategic Focus on Targeted M&A Expansion in Health and CPG Sectors	NE
21/07	Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods	NE
14/07	Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks	NE
08/07	Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap	NE
02/07	Restart Life Sciences Reports Record-Breaking June Revenue for Holy Crap Foods as Amazon Canada Sales Surge YoY	NE
18/06	Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods	NE
10/06	Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch	NE
03/06	Restart Life Sciences Appoints Inez Ho as Chief Financial Officer	NE
21/05	Restart Life Sciences Closes Dedicated Purchase Order Financing Private Placement; CEO Subscribes for 50% of Offering	NE
15/05	Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio	NE
13/05	Restart Life Sciences Leverages Amazon Logistics for Strategic Entry of Holy Crap Foods into U.S. Market	NE
08/05	Restart Life Sciences Announces Dedicated Purchase Order Financing Through Private Placement Offering	NE
08/05	Restart Life Sciences Strengthens Operational Infrastructure to Scale "Better-for-You" Portfolio	NE
07/05	Restart Life Sciences Appoints Capital Markets Veteran Lindsay Hamelin to Board of Directors	NE
05/05	Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY	NE
30/04	Restart Life Advances Holy Crap Growth Strategy with New Protein SKU Nearing Commercialization	NE
28/04	Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Launches on Walmart Canada's Digital Marketplace	NE
23/04	Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Reports over 500,000 Units Sold, Highlighting Strong Consumer Adoption	NE
22/04	Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio	NE
11/03	Restart Life Highlights Certified Manufacturing Platform to Drive Margin Expansion and Distribution Growth	NE
03/03	Restart Life Announces Collaboration with University of Manitoba's Centre for Food Technology and Research	NE
27/02	Restart Life Sciences Closes Acquisition of Holy Crap Foods	NE
13/02	Restart Life Sciences Executes Definitive Agreement to Acquire Holy Crap Foods	NE
22/12	Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan	NE
22/12	Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant	NE